CN1331502C - Chinese medicine composition - Google Patents
Chinese medicine composition Download PDFInfo
- Publication number
- CN1331502C CN1331502C CNB2005100219236A CN200510021923A CN1331502C CN 1331502 C CN1331502 C CN 1331502C CN B2005100219236 A CNB2005100219236 A CN B2005100219236A CN 200510021923 A CN200510021923 A CN 200510021923A CN 1331502 C CN1331502 C CN 1331502C
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- dried products
- medicine
- raw material
- raw materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
A Chinese medicine composition relates to a medical composition, particularly to medicine made by using Chinese medical herbs as raw materials. The present invention is a medicament made by raw materials containing the weight proportion or a plurality of raw materials in the raw materials, and the weight proportion is 15 to 20 of lindernia procumbens, 6 to 12 of agrimonia pilosa, 5 to 12 of gentian, 3 to 8 of barbed skullcap and 3 to 8 of oldenlandia. A producing method for preparing the medicine of the present invention by the components has the procedures: dried products of each raw material is weighed respectively according to the components; the dried products are mixed and then are porphyrized; the dried products are sieved for 3 to 4 times by a fine sieve of 120 meshes to 150 meshes; after the dried products are sterilized, the dried products are respectively encapsulated according to the different dosages of 0.25g, 0.5g, 1g, etc. The product of the present invention has the advantages of wide purpose, obvious therapeutic effect and few and simple raw material on the aspect of disease therapy.
Description
(1) technical field: a kind of Chinese medicine composition, relate to a kind of pharmaceutical composition, especially relating to a kind of is the medicine that raw material is made with the vegetable Chinese herbal medicine.
(2) background technology: Chinese medicine, because of its toxic and side effects is little, the advantage that expense is lower more and more is subject to people's attention.People constantly develop various Chinese medicine compositions in order to treat various diseases such as tuberculosis, cancer, various inflammation.Most of Chinese medicine compositions have been obtained effect preferably.But there is following shortcoming in these Chinese medicine compositions: 1, their purposes aspect the treatment disease are single, can only treat cancer as the medicine of treatment cancer, and the treatment tuberculosis can only be treated tuberculosis, and the medicine of treatment inflammation can only be treated inflammation.2, these Chinese medicine composition medicine materials are formed many and complexity, and these crude drug are tens flavors at least, at most tens flavor even flavors up to a hundred, so directly caused the cost height of medicine own, preparation medicine workload strengthens, and process of preparing Chinese medicine program increases, processed complex, cost improves.3, medicine time long, it is unhappy to take effect, the needs that have reach the several years takes medicine, cure rate is not high.
(3) summary of the invention: the problem to be solved in the present invention provides a kind of, raw material of many uses, evident in efficacy aspect the disease in treatment and forms less and simple Chinese medicine composition.Its technical scheme is that it is made up of the following weight proportion raw material: Lindernia procumbens (Krock.) Phillcox. 15~20, Radix Agrimoniae 6~12, Radix Gentianae 5~12, Herba Scutellariae Barbatae 3~8, Herba Hedyotidis Diffusae 3~8.Above-mentioned each component is made medicine production method of the present invention is: take by weighing each former medicine dry product respectively by above-mentioned component, mix the back porphyrize, sieve 3~4 times with 120 orders~150 order dusting covers, it is encapsulated respectively that various dose such as 0.25g, 0.5g, 1g are pressed in the sterilization back; Or after earlier Lindernia procumbens (Krock.) Phillcox. being soaked 15~20 minutes with clear water, add the common immersion of all the other medicines 1~2 hour again, the clear water that adds should flood powder, heat then until boiling, 15~30 minutes after-filtration 3~4 times seethe with excitement, with static 6~12 hours of filtered liquid medicine, the sterilization back was by the bottling of 50~1000ml various dose.Also can as required this Chinese medicine composition be made powder or piece agent.
Compared with prior art the present invention has following beneficial effect: the Chinese medicine composition of 1, making has heat-clearing and toxic substances removing, antiinflammatory, pain relieving, removing heat from blood, hemostasis, dehumidifying, toxin expelling, eliminating stagnation, relieving constipation and anticancer antineoplastic action, gram coccus, tubercule bacillus, virus, hemolytic coccus is had the effect that suppresses and kill.Of many uses aspect the treatment disease, can be used for treating cancer and benign tumor such as esophageal carcinoma, hepatocarcinoma, liver cirrhosis, leukemia, hysteromyoma; Inflammation such as cholecystitis, tonsillitis, pharyngolaryngitis, appendicitis, pelvic inflammatory disease, gynecological inflammation; Tuberculosis such as lymphoid tuberculosis, tuberculosis of testis, tuberculosis of breast; Also can be used for hemorrhoid, intestinal obstruction, hypertension, drug rehabilitation, sexually transmitted disease (STD), prostatitis, hemorrhage, the fat treatment of gingival swelling and pain; Help the toxin expelling dehumidifying if the normal person takes, build up resistance and immunity.2, the present invention is evident in efficacy, and especially to various inflammation, gingival swelling and pain, tuberculosis, pain relieving, hemorrhoid, hypertension, fat drug treatment weak point, instant effect is generally taken medicine and can be fully recovered in 7~14 days.3, this medicine raw material is formed less and simple, thereby production, processing method and program are simple, thereby the medicine expense is low, and the patient is easy to accept.4, this medicine clinical drug safety has no side effect.
For proving therapeutic effect of the present invention, the present invention did the clinical observation of system to 385 routine patients from 1977~in July, 2005.Man's 258 examples, women 127 examples are between 10 years old to 73 years old age.Cancer patient's 50 examples wherein, heavy inflammation such as cholecystitis, appendicitis, pelvic inflammatory disease, gynecological inflammation 50 examples, tuberculosis 30 examples, intestinal obstruction 15 examples, hemorrhoid 100 examples, other patient's 140 examples.Therapeutic Method is oral, and 2~3 times/day, capsule is obeyed 0.5g~1g (in medication amount) at every turn, and water preparation is obeyed 50ml~100ml at every turn.The criterion of therapeutical effect of various diseases is as the criterion with hospital's testing result and judge.Treatment time, therapeutic outcome, effective percentage, the cure rate of main disease see the following form:
Cancer | Heavy inflammation | Tuberculosis | Intestinal obstruction | Hemorrhoid | ||
Treatment time | 15~30 days mid-terms early, | 7~15 | 10~30 | 1~3 | 4~7 | |
Therapeutic outcome (example) | Recovery from illness | Early stage 30 examples, mid-terms 15 example | 48 | 29 | 14 | 95 |
Effectively | 50 | 50 | 30 | 15 | 100 | |
Invalid | 0 | 0 | 0 | 0 | 0 | |
Effective percentage | 100% | 100% | 100% | 100% | 100% | |
Cure rate | Early stage 90%, mid-term 70~80% | 96% | 96% | 95% | 95% |
For treatment for cancer, be primarily aimed at morning, mid-term patient, as for cancer of late stage, can only disease controlling not worsen, relief of symptoms prolongs patient's life.
Solution of the present invention is based on the pharmacological properties of each raw material:
Lindernia procumbens (Krock.) Phillcox.: its formal name used at school of the 4th the 28th page record of " the Chinese Higher plant illustrated handbook " that Science Press published in 2002 is lindernia procumbens (Krock.).Among the peoplely be used to have a toothache, the treatment of laryngalgia, hemorrhoid, dysentery, sore, concentrate on studies for many years through the inventor, hemorrhage to cancer, hepatosplenomegaly, cholecystitis, swelling and pain of hemorrhoid clinically, toothache, pharyngolaryngitis, ileac treatment special effect also have certain curative effect to gynecological inflammation, sexually transmitted disease (STD), dermatosis, tuberculosis, leukemia, drug rehabilitation, obesity.
Radix Agrimoniae: have another name called Herba Agrimoniae, Main Ingredients and Appearance contains the red crowned crane element, crane shen phenol etc., its bitter in the mouth, suffering, flat.Have invigorating blood circulation, dysentery is detoxified, nourishes, controlled to the pain of stopping blooding, disappear, control function such as haematemesis, effective in cure to esophageal carcinoma, gastric cancer, body nihility power, menoxenia, hepatitis B.
Radix Gentianae: Main Ingredients and Appearance contains gentiopicrin, gentianose, Radix Gentianae alkali, gentisin etc.Main effect is the secretion of facilitating digestion liquid, is good for the stomach, and clearing away heat-damp and promoting diuresis is used for conjunctival congestion and swelling pain, costalgia, and the pudendum pruritus due to damp pathogen swells and ache, the treatment of eczema and pyelonephritis etc.
Herba Scutellariae Barbatae: the little bitter cold of property, have heat-clearing and toxic substances removing, the effect of inducing diuresis to remove edema is used for hepatitis, hepatomegaly, cirrhotic ascites, sore and toxic, snake bite and insect sting also can be used for pulmonary carcinoma, the treatment of hepatocarcinoma, rectal cancer.
Herba Hedyotidis Diffusae: property is sweet, light, cool, has heat-clearing and toxic substances removing, and the effect of dissipating blood stasis eliminating carbuncle is used for the treatment of acute appendicitis, pelvic inflammatory disease, urinary system infection and snakebite, also can be used for the treatment of alimentary tract cancer.
(4) specific embodiment: the production method that relates in the specific embodiment repeats no more as previously mentioned here
Embodiment one:
Take by weighing raw material by following proportioning: (consumption is a weight portion)
Lindernia procumbens (Krock.) Phillcox. 15 Radix Agrimoniaes 6 Radix Gentianaes 5 Herba Scutellariae Barbataes 3 Herba Hedyotidis Diffusaes 3
Embodiment two:
Take by weighing raw material by following proportioning: (consumption is a weight portion)
Lindernia procumbens (Krock.) Phillcox. 20 Radix Agrimoniaes 12 Radix Gentianaes 12 Herba Scutellariae Barbataes 8 Herba Hedyotidis Diffusaes 8
Embodiment three:
Take by weighing raw material by following proportioning: (consumption is a weight portion)
Lindernia procumbens (Krock.) Phillcox. 20 Radix Agrimoniaes 10 Radix Gentianaes 10 Herba Scutellariae Barbataes 5 Herba Hedyotidis Diffusaes 5
Claims (4)
1, a kind of Chinese medicine composition is characterized in that the raw material of Chinese medicine for preparing its active component is made up of following parts by weight of Chinese traditional medicine:
Lindernia procumbens (Krock.) Phillcox. 15~20 Radix Agrimoniaes 6~12 Radix Gentianaes 5~12 Herba Scutellariae Barbataes 3~8 Herba Hedyotidis Diffusaes 3~8
2,, it is characterized in that wherein the weight proportion of each raw material is according to the described Chinese medicine composition of claim 1:
Lindernia procumbens (Krock.) Phillcox. 20 Radix Agrimoniaes 10 Radix Gentianaes 10 Herba Scutellariae Barbataes 5 Herba Hedyotidis Diffusaes 5
3,, it is characterized in that said medicament is a peroral dosage form according to claim 1 or 2 described Chinese medicine compositions.
4,, it is characterized in that said medicament is water preparation, powder, piece agent or capsule according to the described Chinese medicine composition of claim 3.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100219236A CN1331502C (en) | 2005-10-24 | 2005-10-24 | Chinese medicine composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100219236A CN1331502C (en) | 2005-10-24 | 2005-10-24 | Chinese medicine composition |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1772110A CN1772110A (en) | 2006-05-17 |
CN1331502C true CN1331502C (en) | 2007-08-15 |
Family
ID=36759361
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100219236A Expired - Fee Related CN1331502C (en) | 2005-10-24 | 2005-10-24 | Chinese medicine composition |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1331502C (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101502579B (en) * | 2009-03-19 | 2014-01-01 | 山东省医药工业研究所 | Chinese medicinal composition for treating digestive tumor and preparation method thereof |
JP5602049B2 (en) * | 2010-02-19 | 2014-10-08 | 株式会社アルソア本社 | Anti-obesity agents and pharmaceuticals for inhibiting fat accumulation |
CN102600408B (en) * | 2012-03-31 | 2013-06-05 | 曾洁 | Medicine for curing hyperplasia of mammary glands |
CN103230469A (en) * | 2013-04-02 | 2013-08-07 | 常熟市厚福堂健康服务有限公司 | Hemorrhoid rehabilitation traditional Chinese medicine |
CN106418213A (en) * | 2016-09-23 | 2017-02-22 | 惠安县威科电子科技有限公司 | Special food formulation for hyperlipidemic patients to consume and preparation method thereof |
CN110420241B (en) * | 2019-09-02 | 2021-10-22 | 延边大学 | A Chinese medicinal spray for treating prostatitis, and its preparation method |
CN110638898A (en) * | 2019-10-16 | 2020-01-03 | 长沙正源堂生物科技有限公司 | Tianshan Qicaiwangzhu capsule |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1049867A (en) * | 1990-03-22 | 1991-03-13 | 周发祥 | A kind of from radicula byssoidea the method for extracting effective components |
CN1106622A (en) * | 1993-12-09 | 1995-08-16 | 罗纳-普朗克农业化学公司 | Herbicidal composition |
CN1223886A (en) * | 1998-12-03 | 1999-07-28 | 孙景华 | Pathogenic factor eliminating and healthy energy supporting anticancer medicine |
CN1457806A (en) * | 2002-05-15 | 2003-11-26 | 栾一 | Medicine for curing primary carcinoma of liver and its preparing method |
-
2005
- 2005-10-24 CN CNB2005100219236A patent/CN1331502C/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1049867A (en) * | 1990-03-22 | 1991-03-13 | 周发祥 | A kind of from radicula byssoidea the method for extracting effective components |
CN1106622A (en) * | 1993-12-09 | 1995-08-16 | 罗纳-普朗克农业化学公司 | Herbicidal composition |
CN1223886A (en) * | 1998-12-03 | 1999-07-28 | 孙景华 | Pathogenic factor eliminating and healthy energy supporting anticancer medicine |
CN1457806A (en) * | 2002-05-15 | 2003-11-26 | 栾一 | Medicine for curing primary carcinoma of liver and its preparing method |
Also Published As
Publication number | Publication date |
---|---|
CN1772110A (en) | 2006-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1331502C (en) | Chinese medicine composition | |
CN102188685A (en) | Externally-applied traditional Chinese medicine powder for treating diarrhea type irritable bowel syndrome and preparation method thereof | |
CN101129672A (en) | Orally taken traditional Chinese medicine composition for treating bacillary dysentery | |
CN102218086A (en) | Traditional Chinese medicine ointment for treating hemorrhoids | |
CN103920027A (en) | Medicament for treating acute jaundice hepatitis B and preparation method thereof | |
CN107375856A (en) | A kind of cholagogic fossil tea and preparation method thereof | |
CN104887970A (en) | Acupuncture and moxibustion physiotherapy ointment for external use | |
CN103070994B (en) | Plaster for treating cervical and lumbar spondylosis | |
CN115252732B (en) | Traditional Chinese medicine composition for clearing lung and relieving cough and application thereof | |
CN101953911A (en) | Chinese medicinal preparation for treating stomach cancer and preparation method thereof | |
CN101584841B (en) | Gardenia-rhubarb soup for treating acute cholecystitis | |
CN100396305C (en) | Chinese medicinal preparation for treating hyperosteogeny and lumbar vertebra protrusion | |
CN101011512A (en) | Medicine for treating digestive tract tumour and its preparing process | |
CN106266704A (en) | The Chinese medicine composition for the treatment of gastroenteritis and preparation method | |
CN105362944A (en) | Traditional Chinese medicine ointment for treating orthopedics sprain and contusion | |
CN104840698A (en) | Haemorrhoids-treating traditional Chinese medicine composition and preparation method thereof | |
CN104225009A (en) | Traditional Chinese medicine composition for treating diarrhea | |
CN104027789A (en) | Traditional Chinese medicine composition for treating cold retardation type jaundice of newborn babies and preparing method thereof | |
CN104398800A (en) | Traditional Chinese medicinal composition for treating proctitis and preparation method thereof | |
CN103989837A (en) | Traditional Chinese medicine composition for preventing and treating haemorrhoids and preparation method thereof | |
CN103751397B (en) | A kind of Chinese medicine composition for the treatment of pressure ulcer | |
CN103816265A (en) | Drug for treating diarrhea and preparation method thereof | |
CN103316321B (en) | Colitis treatment spray | |
CN109663011A (en) | A kind of medicine group that treating pelvic inflammatory disease is combined and preparation method | |
CN108524639A (en) | A kind of Chinese medicine composition and preparation method thereof for treating pancreatitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070815 Termination date: 20101024 |